Literature DB >> 10841855

Costs of employee smoking in the workplace in Scotland.

S Parrott1, C Godfrey, M Raw.   

Abstract

BACKGROUND: Employers have responded to new regulations on the effects of passive smoking by introducing a range of workplace policies. Few policies include provision of smoking cessation intervention.
OBJECTIVE: To estimate the cost to employers of smoking in the workplace in Scotland to illustrate the potential gains from smoking cessation provision. Costs vary with type of smoking policy in place; therefore, to estimate these costs results from a survey were combined with evidence drawn from a literature review. STUDY
DESIGN: A telephone survey of 200 Scottish workplaces, based on a stratified random sample of workplaces with 50 or more employees, was conducted in 1996. Additional evidence was compiled from a review of the literature of smoking related costs and specific smoking related effects.
RESULTS: 167 completed responses were received, of which 156 employers (93%) operated a smoking policy, 57 (34%) operated smoke free buildings, and 89 (53%) restricted smoking to a "smoke room". The research literature shows absenteeism to be higher among smokers when compared to non-smokers. The estimated cost of smoking related absence in Scotland is pound40 million per annum. Total productivity losses are estimated at approximately pound450 million per annum. In addition, the resource cost in terms of losses from fires caused by smoking materials is estimated at approximately pound4 million per annum. In addition, there are costs from smoking related deaths and smoking related damage to premises.
CONCLUSION: This study shows how smoking cessation interventions in the workplace can yield positive cost savings for employers, resulting in gains in productivity and workplace attendance which may outweigh the cost of any smoking cessation programme.

Entities:  

Mesh:

Year:  2000        PMID: 10841855      PMCID: PMC1748323          DOI: 10.1136/tc.9.2.187

Source DB:  PubMed          Journal:  Tob Control        ISSN: 0964-4563            Impact factor:   7.552


  12 in total

1.  The friction cost method for measuring indirect costs of disease.

Authors:  M A Koopmanschap; F F Rutten; B M van Ineveld; L van Roijen
Journal:  J Health Econ       Date:  1995-06       Impact factor: 3.883

2.  A total ban on workplace smoking is acceptable and effective.

Authors:  B Hocking; R Borland; N Owen; G Kemp
Journal:  J Occup Med       Date:  1991-02

3.  The health care costs of smoking.

Authors:  J J Barendregt; L Bonneux; P J van der Maas
Journal:  N Engl J Med       Date:  1997-10-09       Impact factor: 91.245

4.  The effects of behavioral risks on absenteeism and health-care costs in the workplace.

Authors:  R L Bertera
Journal:  J Occup Med       Date:  1991-11

5.  The cost of smoking in Canada, 1991.

Authors:  M J Kaiserman
Journal:  Chronic Dis Can       Date:  1997

6.  Impact of a restrictive work site smoking policy on smoking behavior, attitudes, and norms.

Authors:  N H Gottlieb; M P Eriksen; C Y Lovato; R P Weinstein; L W Green
Journal:  J Occup Med       Date:  1990-01

7.  Illness absence at an oil refinery and petrochemical plant.

Authors:  S P Tsai; E L Gilstrap; T A Colangelo; A K Menard; C E Ross
Journal:  J Occup Environ Med       Date:  1997-05       Impact factor: 2.162

8.  Smoking and excess sick leave in a department of health.

Authors:  M Van Tuinen; G Land
Journal:  J Occup Med       Date:  1986-01

Review 9.  Economic implications of workplace health promotion programs: review of the literature.

Authors:  K E Warner; T M Wickizer; R A Wolfe; J E Schildroth; M H Samuelson
Journal:  J Occup Med       Date:  1988-02

10.  Cost to industry of illnesses related to alcohol and smoking. A study of Telecom Australia employees.

Authors:  B Hocking; H Grain; I Gordon
Journal:  Med J Aust       Date:  1994-10-03       Impact factor: 7.738

View more
  15 in total

1.  A prospective investigation of the impact of smoking bans on tobacco cessation and relapse.

Authors:  D R Longo; J C Johnson; R L Kruse; R C Brownson; J E Hewett
Journal:  Tob Control       Date:  2001-09       Impact factor: 7.552

2.  Smoking cessation in chronic obstructive pulmonary disease: an effective medical intervention.

Authors:  Stefan Andreas; Thomas Hering; Stephan Mühlig; Dennis Nowak; Tobias Raupach; Heinrich Worth
Journal:  Dtsch Arztebl Int       Date:  2009-04-17       Impact factor: 5.594

3.  Local governments' dependence on tobacco tax revenue: a deterrent to tobacco control in the Republic of Korea.

Authors:  Young Kyung Do; Kidong Park
Journal:  Bull World Health Organ       Date:  2009-09       Impact factor: 9.408

4.  Beliefs regarding smoking in the workplace: results from the Global Workplace Smoking Survey.

Authors:  Michael T Halpern; Humphrey Taylor
Journal:  Int J Public Health       Date:  2009-10-30       Impact factor: 3.380

5.  Workplace smoking related absenteeism and productivity costs in Taiwan.

Authors:  S P Tsai; C P Wen; S C Hu; T Y Cheng; S J Huang
Journal:  Tob Control       Date:  2005-06       Impact factor: 7.552

6.  Voluntary Smoke-Free Measures Among Oklahoma Nightlife Owners: Barriers and Facilitators.

Authors:  Carson Benowitz-Fredericks; Julia McQuoid; Nicolas Sheon; Sarah Olson; Pamela M Ling
Journal:  Health Promot Pract       Date:  2018-04-02

Review 7.  The Economic Impact of Smoking and of Reducing Smoking Prevalence: Review of Evidence.

Authors:  Victor U Ekpu; Abraham K Brown
Journal:  Tob Use Insights       Date:  2015-07-14

8.  Illegal passive smoking at work.

Authors:  François-Xavier Lesage; Frédéric Deschamps; Denisa Jurca
Journal:  Adv Prev Med       Date:  2011-03-31

9.  Pattern of smoking habit among Greek blue and white collar workers.

Authors:  George Rachiotis; Ioannis Karydis; Spyros Drivas; Christos Hadjichristodoulou
Journal:  Int J Environ Res Public Health       Date:  2009-06-10       Impact factor: 3.390

10.  An analysis of the economic impact of smoking cessation in Europe.

Authors:  David Cohen; M Fasihul Alam; Paul S Jarvis
Journal:  BMC Public Health       Date:  2013-04-25       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.